Evidence map›Paper›PMID 26783136›Full record

ArticleNature communications2016

Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesion.

Yusuke Yamamoto, Xia Wang, Denis Bertrand, Florian Kern, Ting Zhang, Marcin Duleba, Supriya Srivastava, Chiea Chuen Khor, Yuanyu Hu, Lane H Wilson and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Mapping the adult human esophagus in vivo and in vitro.Development (Cambridge, England) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Concept and research progress of precancerous lesions].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  15. Esophageal Tumor Microenvironment.Advances in experimental medicine and biology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yusuke YamamotoDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Xia WangDepartment of Biology and Biochemistry, University of Houston, Houston, Texas 77204, USA.
Denis BertrandDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Florian KernDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Ting ZhangDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Marcin DulebaDepartment of Biology and Biochemistry, University of Houston, Houston, Texas 77204, USA.
Supriya SrivastavaDepartment of Pathology, National University Heath System, Singapore 119228, Singapore.
Chiea Chuen KhorDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Yuanyu HuDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Lane H WilsonDepartment of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Hagen BlaszykDigestive Health Center, Maine Medical Center, South Portland, Maine 04102, USA.
Daniil RolshudDigestive Health Center, Maine Medical Center, South Portland, Maine 04102, USA.
Ming TehDepartment of Pathology, National University Heath System, Singapore 119228, Singapore.
Jianjun LiuDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Brooke E HowittDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Matthew VincentOcata Therapeutics, Inc., Marlborough, Massachusetts 01752, USA.
Christopher P CrumDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Niranjan NagarajanDepartment of Computational &Systems Biology, Genome Institute of Singapore, A-STAR, Singapore 138672, Singapore.
Khek Yu HoDepartment of Medicine, National University of Singapore, Singapore 119228, Singapore.
Frank McKeonDepartment of Biology and Biochemistry, University of Houston, Houston, Texas 77204, USA.
Wa XianDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precancerous lesion known as Barrett's oesophagus can evolve to oesophageal adenocarcinoma in decades-long processes of regenerative growth. Here we report the isolation and propagation of distinct, patient-matched stem cells of Barrett's, gastric and oesophageal epithelia that yield divergent tumour types following in vitro transformation and xenografting. Genomic analyses reveal a broad mutational spectrum unique to Barrett's stem cells that likely reflects their risk for oncogenesis. Remarkably, 25% of cases show no cancer-related genomic changes, suggesting that Barrett's initiates without driver mutations. Most cases, however, sustain patterns of deletions almost identical to adenocarcinoma though tumour-associated gene amplifications were absent. Notably, those suspected of low-grade dysplasia have p53 mutations or undergo amplifications of proto-oncogenes and receptor tyrosine kinases, implicating these events in lethal transitions. Our findings suggest paths for the initiation and progression of Barrett's and define a discrete stem cell underlying its regenerative growth whose eradication could prevent oesophageal adenocarcinoma.

Indexed as

AnimalsBarrett EsophagusCell DifferentiationCells, CulturedHumansMaleMiceMutationPrecancerous ConditionsStem CellsTumor Cells, Cultured

Identifiers

PMID26783136
PMCPMC4735693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.